How common is attention deficit hyperactivity disorder (ADHD) in a cohort of children with functional constipation,

Hassan Bazmamoun1, Alireza Momeni1, Leila Jahangard1

  • 1Department of Pediatrics, Hamadan University of Medical Sciences, Hamadan, Iran.

Insights

Attention deficit hyperactivity disorder (ADHD) treatment did not improve functional constipation in children. Treating both ADHD and constipation simultaneously significantly improved constipation recovery rates.

Area of Science:

  • Pediatrics
  • Neurodevelopmental Disorders
  • Gastroenterology

Background:

  • Attention deficit hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder in children.
  • Functional constipation significantly impacts children's quality of life, affecting physical and emotional well-being.

Purpose of the Study:

  • To determine the frequency of ADHD in children with functional constipation.
  • To evaluate the effect of ADHD treatment on functional constipation recovery.

Main Methods:

  • A clinical trial involving 80 children diagnosed with both ADHD and functional constipation.
  • Participants were randomized into two groups: one treated for ADHD only, the other for both conditions.
  • Treatment outcomes for constipation were assessed in both groups.

Main Results:

  • The frequency of ADHD among children with functional constipation was 13.87%.
  • Functional constipation recovery rates were 5% in the ADHD-only treatment group versus 97.5% in the combined treatment group (p < 0.001).
  • ADHD treatment alone did not significantly impact constipation recovery.

Conclusions:

  • Treating ADHD does not improve functional constipation in children.
  • Simultaneous treatment of both ADHD and functional constipation is highly effective for constipation recovery.
  • No significant relationship was found between treatment response and patient age, sex, or duration of conditions.
Abstract

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
135
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
247
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
237
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
210
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
259
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
267